Investor Presentation March 2026 Disclaimer Forward-Looking Statements This presentation has been prepared by Lumexa Imaging Holdings, Inc. ("Lumexa Imaging," the "Company" or "we") and contains forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements regarding our future results of operations and financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. T ...

Lumexa Imaging FY Conference Summary Company Overview - **Company**: Lumexa Imaging (NasdaqGS:LMRI) - **IPO Date**: December 2025 - **Industry**: Radiology - **Position**: Second-largest outpatient imaging platform in the U.S. with 189 centers located in high-growth metropolitan statistical areas (MSAs) [10][12] Key Highlights - **Market Dynamics**: The radiology sector is experiencing growth, with a total addressable market (TAM) of $140 billion, growing at a 4% CAGR. Outpatient imaging specifically has a TAM of $33 billion, growing at a 7% CAGR [17] - **Revenue Mix**: 63% of revenue comes from commercial payers, with advanced imaging accounting for 63% of revenue and 35% of volume [15][18] - **Patient Satisfaction**: Achieved a Net Promoter Score (NPS) of 91, indicating high patient satisfaction [14] Growth Strategy - **Expansion**: Completed 9 de novo openings in 2025, with plans to open 8-10 new centers annually [13][32] - **Joint Ventures (JVs)**: Engages in partnerships with health systems to diversify outpatient ancillary revenue, typically sharing capital and operational responsibilities [21][22] - **Cost Efficiency**: Operates at 60% lower costs compared to hospital outpatient departments, enhancing value for payers and patients [17] Financial Performance - **Revenue per Scan**: Revenue per scan in JVs is approximately $370, compared to $225 consolidated and $165 for competitors like RadNet, attributed to a higher acuity mix in JVs [54][58] - **Operating Metrics**: The outpatient imaging segment is growing at 7%-9%, while the inpatient pro fee segment is growing at 5% [33][42] - **Margin Expansion**: Expected pro forma margin growth of 7.2% in 2026, with a historical CAGR of 7%-8% [43][45] Risks and Considerations - **Routine Imaging Volumes**: There is expected softness in routine imaging volumes, particularly X-ray, which may not significantly impact overall financials [52][53] - **Capital Expenditure**: Anticipated increase in capital spending from approximately $30 million to $80 million annually, primarily for de novo openings and technology upgrades [59][60] Additional Insights - **Fragmentation in Industry**: The imaging industry is highly fragmented, with significant opportunities for growth through acquisitions, especially among smaller sites [19][36] - **Technological Advancements**: Focus on improving efficiency through innovations like fast scan technology and virtual MRI, which are not included in current growth forecasts [33][34] Conclusion Lumexa Imaging is positioned for significant growth in the radiology sector, leveraging its strong market position, strategic partnerships, and focus on advanced imaging. The company is actively pursuing expansion through new center openings and joint ventures while maintaining a commitment to cost efficiency and patient satisfaction.

Exhibit 99.1 Lumexa Imaging Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Results; Provides 2026 Financial Guidance and Earnings Conference Call Date RALEIGH, NORTH CAROLINA, March 2, 2026—Lumexa Imaging Holdings, Inc. ("Lumexa Imaging" or "we"), one of the nation's largest providers of outpatient imaging services, today announced certain preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025. The financial results included in this release pe ...

Core Insights - Lumexa Imaging's Dr. Jennifer L. Kemp has been elected to the Board of Directors of the Radiological Society of North America (RSNA), highlighting the company's clinical leadership and commitment to quality in radiology [1][2] Company Overview - Lumexa Imaging is a leading provider of outpatient imaging services in the U.S., operating over 185 imaging centers across 13 states and employing more than 5,000 team members [5] - The company conducted approximately 4 million outpatient scans in 2024, positioning itself as a partner of choice for health systems and radiologists [5] Leadership and Innovation - Dr. Kemp's election to the RSNA Board emphasizes the importance of physician leadership in shaping the future of radiology, particularly in the context of growth, AI innovation, and evolving policies [2][4] - As Chief of Patient Experience at Scanslated, Dr. Kemp leads initiatives to enhance patient understanding of radiology results, utilizing AI-driven software to translate complex reports into accessible language [2] Patient Engagement - Lumexa Imaging patients have accessed over 2 million reports through the Scanslated platform, with 99% of surveyed patients indicating that patient-friendly explanations positively influence their likelihood to choose Lumexa Imaging centers in the future [3]

Lumexa Imaging FY Conference Summary Company Overview - **Company Name**: Lumexa Imaging (NasdaqGS:LMRI) - **Industry**: Diagnostic Imaging - **Market Size**: $140 billion Total Addressable Market (TAM) growing at a 4% CAGR; Outpatient sector at $33 billion TAM growing at a 7% CAGR [7][22] Key Points Industry Dynamics - Diagnostic imaging is a dynamic industry driven by an aging population and advancements in treatment paradigms requiring advanced imaging technologies such as MRI, CT, and PET scans [7][22] - The outpatient imaging sector is experiencing significant growth, with a shift towards lower-cost service centers [22][18] Company Positioning - Lumexa Imaging is the second largest platform in the outpatient imaging space with 188 sites across 13 states, focusing on high-growth markets [7][8] - The company operates a scalable model with a strong joint venture partnership strategy, having completed 44 de novos since inception, including a record nine in the past year [9][12] Financial Metrics - Advanced imaging accounts for 63% of revenue and 36% of volume, indicating a premium revenue model [13][27] - The company has a 97% patient satisfaction rate and an NPS of 91, significantly higher than industry benchmarks [12][15] - Revenue from outpatient imaging centers constitutes over 80% of total revenue and EBITDA [10][12] Growth Strategy - Lumexa aims to continue expanding through de novos and acquisitions, targeting 8-10 new centers annually [9][50] - The company emphasizes same-store growth by maximizing schedules and building referral relationships [48][49] - There is a focus on leveraging advanced technology, including AI, to enhance operational efficiency and patient care [10][33] Joint Venture Model - The joint venture model with health systems allows for shared capital expenditures and operational efficiencies, differentiating Lumexa from competitors [51][52] - The company has identified over 100 potential health system partners across top markets, many of whom currently lack imaging partnerships [43] Labor Market and Staffing - Lumexa benefits from a favorable labor market for radiologists and technologists, with better retention rates than industry averages [53] - The company provides flexibility and job satisfaction for staff, contributing to lower turnover [53] Future Outlook - The company is focused on maintaining a strong balance sheet while pursuing growth opportunities, with a commitment to transparency and communication with stakeholders [49][56] - Investors are expected to appreciate the consistency and quality of Lumexa's growth as it continues to establish itself as a leading outpatient imaging provider [55] Additional Insights - The outpatient imaging industry remains highly fragmented, with Lumexa and its largest competitor, RadNet, accounting for less than 10% of the market [25] - The company’s operational model allows for quick scalability and adaptability in response to market demands [30][41] - Lumexa's strategic partnerships and technology investments are designed to enhance patient experience and operational efficiency, positioning the company for sustained growth [34][36]

Lumexa Imaging FY Conference Summary Company Overview - **Company**: Lumexa Imaging (NasdaqGS:LMRI) - **Industry**: Healthcare, specifically outpatient imaging - **Market Size**: - Total Addressable Market (TAM): $140 billion, growing at a 4% CAGR - Outpatient sector TAM: $33 billion, growing at a 7% CAGR driven by aging population and advancements in treatment paradigms [7][24] Core Business Insights - **Operational Scale**: - Second largest platform with 188 imaging sites across 13 states [7][8] - Strong joint venture partnerships with notable health systems like Baylor, Scott, and White, Advocate, Intermountain, and UPMC [13][14] - **Revenue Composition**: - Outpatient imaging centers account for over 80% of revenue in EBITDA [11] - Advanced imaging (MRI, CT, PET scans) constitutes 63% of revenue and 36% of volume, indicating a premium revenue model [14][29] Growth Strategy - **De Novo and Acquisition Strategy**: - 44 de novos since inception, with a record of 9 in the past year [9][52] - Targeting 8 to 10 de novos annually moving forward [52] - Fragmented industry presents M&A opportunities, with over 75% of centers not affiliated with top players [46] - **Joint Venture Model**: - Focus on cultural alignment and transparency with health system partners [54] - Joint ventures allow for shared capital expenditures and operational efficiencies [19][54] Financial Performance - **Revenue Growth**: - High single-digit growth in EBITDA and 6%-7% growth in revenue [22][23] - System-wide metrics provide a comprehensive view of financial health, including revenues from unconsolidated joint ventures [21] - **Cost Efficiency**: - Operating costs are significantly lower than hospital outpatient departments (HOPDs), with a 60% cost advantage [19] Technology and Innovation - **AI and Technology Integration**: - Emphasis on partnerships with best-in-breed technology providers to enhance operational efficiency and patient care [34][35] - AI is expected to improve imaging interpretation speed and accuracy, driving operational efficiencies [36] Patient and Physician Satisfaction - **Satisfaction Metrics**: - 97% patient satisfaction rate and 91 Net Promoter Score (NPS), outperforming major brands like Apple and Netflix [12] - 88% referring physician satisfaction rate, highlighting the ease of referrals and quick turnaround times [13][16] Market Position and Future Outlook - **Market Fragmentation**: - Less than 10% market share in a highly fragmented industry, indicating significant growth potential [27] - **Strategic Priorities for 2026**: - Focus on same-store growth, geographic expansion, and maximizing strategic service lines [50][51] - Continued emphasis on leveraging advanced technology to enhance service delivery and operational efficiency [50] Conclusion - Lumexa Imaging is positioned for robust growth in the outpatient imaging sector, leveraging its operational scale, strategic partnerships, and innovative technology to capture market share and enhance patient care. The company aims to maintain a strong focus on execution while exploring new growth avenues through de novos and potential acquisitions.

Company Overview - Lumexa Imaging is a national outpatient imaging platform with the 2nd largest outpatient imaging center footprint across 13 states[12] - The company provides advanced (MRI, CT, PET) and routine (X-ray, ultrasound, mammography) diagnostic imaging services[12] - As of December 31, 2025, Lumexa Imaging has established 44 de novo sites since its formation[12] Financial Performance (LTM 9/30/25) - Consolidated GAAP Revenue is $1,003 million[17] - Adjusted EBITDA is $220 million with a 22% margin[17] - System-wide revenue from advanced imaging accounts for 63% of the total[17] Market and Growth - The US diagnostic imaging services market was valued at $140 billion in 2024, with a CAGR of 5.9% from 2019[28] - Advanced imaging (MRI, CT) is driving market growth, with a revenue growth of 5.7% from 2019-2024, more than double the routine imaging growth of 2.6%[31] - Lumexa Imaging operates in attractive geographies with ~0.6% to ~1.4% population growth, approximately 2x the US average[38] Technology and AI - The company is leveraging an ecosystem of innovation with ongoing implementation of AI tools[63, 65] - Approximately 45% MRI Fast Scan implementation[67] - Approximately 10% of CPT coding automated[67] Health System Partnerships - Lumexa Imaging has 8 joint ventures across 86 centers[21] - The company takes 49% ownership of JV[86]

Core Viewpoint - The article discusses the author's investment philosophy, which incorporates various strategies including fundamental, technical, and momentum investing, aimed at enhancing the investment process [1]. Group 1 - The author emphasizes a diversified investment approach, leveraging the strengths of fundamental, technical, and momentum investing [1]. - The purpose of writing on Seeking Alpha is to track investment ideas and connect with like-minded investors [1].

Core Insights - Lumexa Imaging has opened nine new outpatient imaging centers in 2025, setting a company record and expanding its operations to over 185 centers across 13 states [1][2][3] Company Expansion - The two latest centers opened in December 2025 are located in Anderson, South Carolina, and Cotswold, North Carolina, contributing to the company's growth strategy [1][2] - The previous openings in 2025 occurred in New York, South Carolina, and Texas, indicating a strategic focus on high-growth metropolitan areas [1][2] Strategic Vision - CEO Caitlin Zulla emphasized the company's commitment to improving patient lives and expanding access to high-quality imaging services through compassionate care [2] - The company aims to continue its de novo growth strategy in 2026, both independently and with joint venture partners, to enhance healthcare access nationwide [2][3] Market Position - Lumexa Imaging has established itself as one of the largest providers of outpatient imaging services in the U.S., conducting approximately 4 million outpatient scans in 2024 [3] - The company is recognized as a partner of choice for health systems and radiologists, delivering clinical excellence and state-of-the-art technology [3]

Company Overview - Lumexa Imaging Holdings, Inc. is one of the largest providers of outpatient imaging services in the United States [1] - As of September 30, 2025, the company operates the second largest outpatient imaging center footprint in the country, with 184 centers across 13 states [2] - The company has eight joint venture partnerships with health systems [2] Upcoming Events - Caitlin Zulla, CEO, and Tony Martin, CFO, will participate in the 44th Annual J.P. Morgan Healthcare Conference [1] - The presentation is scheduled for January 12, 2026, at 7:30am PST [1] - A webcast link and related presentation materials will be available online [1]